Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9766450rdf:typepubmed:Citationlld:pubmed
pubmed-article:9766450lifeskim:mentionsumls-concept:C0013935lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C0026900lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C0229601lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C0072473lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C1332710lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C1546856lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9766450lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9766450pubmed:issue11lld:pubmed
pubmed-article:9766450pubmed:dateCreated1998-10-22lld:pubmed
pubmed-article:9766450pubmed:abstractTextCD34 is a cell-surface glycoprotein expressed in a developmental, stage-specific manner by bone marrow stem and progenitor cells. In this study we explored a possible role for c-Myb in CD34 regulation during developmental hematopoiesis. The results indicate that c-Myb can induce CD34 expression in hematopoietic and nonhematopoietic cells, and that murine CD34 promoter activity is enhanced in myeloid cells transgenic for c-Myb. To test whether c-Myb is necessary for CD34 expression during developmental hematopoiesis in vitro, c-Myb-null D3 embryonic stem (ES) cells were analyzed for their ability to develop CD34+ hematopoietic cells in vitro. CD34 promoter activity in transient transfections and CD34 upregulation during ES cell differentiation into embryoid bodies was identical in wild-type and c-Myb-null ES cells, indicating that c-Myb is not required for CD34 expression. CD34 protein is expressed on both hematopoietic and endothelial cells of the E8.5 blood islands during the development of c-Myb-null embryos, and expression is nearly identical in wild-type and c-Myb-null embryos. However, in E12.5 c-Myb-null embryos, the majority of identifiable CD34+ cells in the developing liver are endothelial rather than hematopoietic, which is consistent with the absence of colony-forming units in c-Myb-null embryos and developing ES cells. These data indicate that c-Myb is not required for CD34 expression in endothelial or primitive hematopoietic cells in the yolk sac, but is necessary for definitive hematopoiesis.lld:pubmed
pubmed-article:9766450pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766450pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766450pubmed:languageenglld:pubmed
pubmed-article:9766450pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766450pubmed:citationSubsetIMlld:pubmed
pubmed-article:9766450pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9766450pubmed:statusMEDLINElld:pubmed
pubmed-article:9766450pubmed:monthOctlld:pubmed
pubmed-article:9766450pubmed:issn0301-472Xlld:pubmed
pubmed-article:9766450pubmed:authorpubmed-author:MauW WWWlld:pubmed
pubmed-article:9766450pubmed:authorpubmed-author:MucenskiM LMLlld:pubmed
pubmed-article:9766450pubmed:authorpubmed-author:KrauseD SDSlld:pubmed
pubmed-article:9766450pubmed:authorpubmed-author:LawlerA MAMlld:pubmed
pubmed-article:9766450pubmed:issnTypePrintlld:pubmed
pubmed-article:9766450pubmed:volume26lld:pubmed
pubmed-article:9766450pubmed:ownerNLMlld:pubmed
pubmed-article:9766450pubmed:authorsCompleteYlld:pubmed
pubmed-article:9766450pubmed:pagination1086-92lld:pubmed
pubmed-article:9766450pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:meshHeadingpubmed-meshheading:9766450-...lld:pubmed
pubmed-article:9766450pubmed:year1998lld:pubmed
pubmed-article:9766450pubmed:articleTitleCD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb.lld:pubmed
pubmed-article:9766450pubmed:affiliationJohns Hopkins Oncology Center and Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Maryland, USA.lld:pubmed
pubmed-article:9766450pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9766450pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9766450pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:9766450pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12490entrezgene:pubmedpubmed-article:9766450lld:entrezgene
entrez-gene:17863entrezgene:pubmedpubmed-article:9766450lld:entrezgene